Abstract
Microembolic signals (MES) are detected by transcranial Doppler (TCD), and are mainly observed in cardiac and large-artery diseases; however they might also be observed in conditions affecting small vessels of the brain. We aimed to review the current medical literature related to MES assessed by TCD in patients with cerebral small vessel disease. We conducted a systematic review in PubMed and selected the articles with information on this topic. Systemic lupus erythematosus (SLE) is the disease with more articles; pooled data showed a frequency of MES of 14.9%. MES were more frequent in SLE patients with antiphospholipid antibodies and ischemic stroke. MES have also been described in other diseases such as primary antiphospholipid syndrome, Sneddon’s syndrome, and Behçet’s disease. Further studies assessing the significance of MES in the pathogenesis of neurological manifestations of these disorders is warranted.
Similar content being viewed by others
References
Aaslid R, Markwalder TM, Nornes H (1982) Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 57:769–774
Ad Hoc Committee on Lupus Response Criteria: cognition-subcommittee, Mikdashi JA, Esdaile JM, Alarcón GS, Crofford L, Fessler BJ, Shanberg L, Brunner H, Gall V, Kalden JR, Lockshin MD, Liang MH, Roberts N Jr, Schneider M (2007) Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. Lupus 16:418–425
Austen W, Howry D (1964) Ultrasound as a method to detect bubbles or particulate matter in the arterial line during cardiopulmonary bypass. J Surg Res 5:283–284
Baizabal-Carvallo JF, Cantú-Brito C, García-Ramos GS (2008) Acute neurolupus manifested by seizures is associated with high frequency of abnormal cerebral blood flow velocities. Cerebrovasc Dis 25:348–354
Brey RL, Escalante A (1998) Neurological manifestations of antiphospholipid antibody syndrome. Lupus 7(Suppl 2):67–74
Cantú-Brito C, Baizabal-Carvallo JF, Alonso-Juárez M, García-Ramos GS (2009) The clinical significance of microembolic signals in systemic lupus erythematosus. Neurol Res (in press)
Caplan LR (2003) Small deep brain infarcts. Stroke 34:658–659
Crutchfield K, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, Schiffmann R (1998) Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50:1746–1749
Csépány T, Valikovics A, Fülesdi B, Kiss E, Szegedi G, Csiba L (1995) Transcranial Doppler may reveal asymptomatic cerebral vasculopathy in systemic lupus erythematosus. Cerebrovasc Dis 5:178–181
Daffertshofer M, Ries S, Schminke U, Hennerici M (1996) High-intensity transient signals in patients with cerebral ischemia. Stroke 27:1844–1849
Dahl A, Omdal R, Waterloo K, Joakimsen O, Jacobsen EA, Koldingsnes W, Mellgren SI (2006) Detection of cerebral embolic signals in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 77:774–779
D’Cruz DP, Khamashta MA, Hughes GRV (2007) Systemic lupus erythematosus. Lancet 369:587–596
Del Sette M, Angeli S, Stara I, Finocchi C, Gandolfo C (1997) Microembolic signals with serial transcranial Doppler monitoring in acute focal ischemic deficit. A local phenomenon? Stroke 8:1311–1313
Dittrich R, Ringelstein B (2008) Ocurrence and clinical impact of microembolic signals during or after cardiosurgical procedures. Stroke 39:503–511
Droste DW, Dittrich R, Hermes S, Kemeny V, Schulte-Altedorneburg G, Hansberg T, Ringelstein EB (1999) Four-gated transcranial Doppler ultrasound in the detection of circulating microemboli. Eur J Ultrasound 9:117–125
Droste DW, Hansberg T, Kemeny V, Hammel D, Schulte-Altedorneburg G, Nabavi DG, Kaps M, Scheld HH, Ringelstein EB (1997) Oxygen inhalation can differentiate gaseous from nongaseous microemboli detected by transcranial Doppler ultrasound. Stroke 28:2453–2456
Fellgiebel A, Muller MJ, Ginsberg L (2006) CNS manifestations of Fabry’s disease. Lancet Neurol 5:791–795
Francès C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC (1999) Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Medicine 78:209–219
Hanly JG, Walsh NM, Sangalang V (1992) Brain pathology in systemic lupus erythematosus. J Rheumatol 19:732–741
Kawai M, Hiroata S (2000) Cerebrospinal fluid beta(2)-microglobulin in neuro-Behçet’s syndrome. J Neurol Sci 179:132–139
Kiernan RJ, Mueller J, Langston JW, van Dyke C (1987) The neurobehavioral cognitive status examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med 107:481–485
Kozora E, Hanly JG, Lapteva L, Filley CM (2008) Cognitive dysfunction in systemic lupus erythematosus. Past, present, and future. Arthritis Rheum 58:3286–3298
Kron J, Hamper UM, Petri M (2001) Prevalence of cerebral microemboli in systemic lupus erythematosus: transcranial Doppler. J Rheumatol 28:2222–2225
Kumral E, Evyapan D, Aksu K, Keser G, Kabasakal Y, Balkir K (2002) Microembolus detection in patients with Takayasu’s arteritis. Stroke 33:712–716
Kumral E, Evyapan D, Oksel F, Keser G, Bereketoğlu MA, Balkir K (1999) Transcranial Doppler detection of microembolic signals in patients with Behçet’s disease. J Neurol 246:592–595
Kumral E, Evyapan D, Keser G, Kabasakal Y, Oksel F, Aksu K, Balkir K (2002) Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus. Eur Neurol 47:131–135
Levine JS, Branch DW, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752–763
Mazzucco S, Anzola GP, Ferrarini M, Taioli F, Olivato S, Burlina AP, Fabrizi GM, Rizzuto N (2009) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy and right-to-left shunt: lack of evidence for an association in a prevalence study. Eur Neurol 61:46–49
McLean BN, Miller D, Thompson EJ (1995) Oligoclonal banding of IgG in CSF, blood–brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet’s disease involving the nervous system. J Neurol Neurosurg Psychiatry 58:548–554
Mitsias P, Levine SR (1996) Cerebrovascular complications of Fabry′s disease. Ann Neurol 40:8–17
Moore DF, Altarescu G, Ling GSF, Jeffries N, Frei KP, Weibel T, Charria-Ortiz G, Ferri R, Arai AE, Brady RO, Schiffmann R (2002) Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 33:525–531
Nakajima M, Kimura K, Shimode A, Miyashita F, Uchino M, Naritomi H, Minematsu K (2007) Microembolic signals within 24 hours of stroke onset and diffusion-weighted MRI abnormalities. Cerebrovasc Dis 23:282–288
Pfefferkorn T, von Stuckrad-Barre S, Herzog J, Gasser T, Hamann GF, Dichgans M (2001) Reduced cerebrovascular CO(2) reactivity in CADASIL: a transcranial Doppler sonography study. Stroke 32:17–21
Rademacher J, Sohngen D, Specker C, Janda I, Sitzer M (1999) Cerebral microembolism, a disease marker for ischemic cerebrovascular events in the antiphospholipid syndrome of systemic lupus erythematosus? Acta Neurol Scand 99:356–361
Rapp JH, Pan XM, Neumann M, Hong M, Hollenbeck K, Liu J (2008) Microemboli composed of cholesterol crystals disrupt the blood–brain barrier and reduce cognition. Stroke 39:2354–2361
Ritter MA, Dittrich R, Thoenissen N, Ringelsten EB, Nabavi DG (2008) Prevalence and prognostic impact of microembolic signals in arterial sources of embolism. J Neurol 255:953–961
Ritter M, Dittrich R, Droste DW (2003) Microembolus detection in four patients with Fabry’s disease: further support for a primarily microangiopathic origin of early cerebrovascular symptoms. Eur Neurol 50:141–145
Roman MJ, Shanker B-A, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE (2003) Prevalence and correlations of accelerated atherosclerosis in systemic lupus erythematosus. New Engl J Med 349:2399–2406
Rovaris M, Viti B, Ciboddo G, Gerevini S, Capra R, Iannucci G, Comi G, Filippi M (2000) Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetization transfer imaging study. J Neurol Neurosurg Psychiatry 68:170–177
Russell D (2002) Cerebral microemboli and cognitive impairment. J Neurol Sci 203–204:211–214
Russell D, Madden KP, Clark WM, Sandset PM, Zivin JA (1991) Detection of arterial emboli using Doppler ultrasound in rabbits. Stroke 22:253–258
Sakai K, Nakajima T, Fukuhara N (2006) Transient elevation of the number of microembolic signal in a patient with primary antiphospholipid antibody syndrome. No To Shinkei 58:439–442
Selnes OA, Goldsborough MA, Borowicz LM, McKhann GM (1999) Neurobehavioural sequelae of cardiopulmonary bypass. Lancet 353:1601–1606
Sitzer M, Söhngen D, Siebler M, Specker Ch, Rademacher J, Janda I, Aulich A, Steinmetz H (1995) Cerebral microembolism in patients with Sneddon’s syndrome. Arch Neurol 52:271–275
Siva A, Altintas A, Saip S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17:347–357
Specker C, Perniok A, Brauckmann U, Siebler M, Schneider M (1998) Detection of cerebral microemboli in APS––introducing a novel investigation method and implications of analogies with carotid artery disease. Lupus 7(Suppl 2):75–80
Specker C, Rademacher J, Söhngen D, Sitzer M, Janda I, Siebler M, Steinmetz H, Schneider M (1997) Cerebral microemboli in patients with antiphospholipid syndrome. Lupus 6:638–644
Spencer MP, Campbell SD, Sealy JL, Henry FC, Lindbergh J (1969) Experiments on decompression bubbles in the circulation using ultrasonic and electromagnetic flowmeters. J Occup Med 11:238–244
Spencer MP, Thomas GI, Nicholls SC, Sauvage LR (1990) Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke 21:415–423
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Wong KS, Gao S, Chan YL, Hansberg T, Lam WW, Droste DW, Kay R, Ringelstein EB (2002) Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 52:74–81
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baizabal-Carvallo, J.F., Samson, Y. Microembolic signals in systemic lupus erythematosus and other cerebral small vessel diseases. J Neurol 257, 503–508 (2010). https://doi.org/10.1007/s00415-009-5421-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5421-y